Suraksha’s margin improves as Q2 revenue growth edges past cost growth
Consolidated net profit grew 16.34% sequentially, though interest expense rose 30.11% and other income contributed 7.95% of pre-tax profit.
Filed 10 Nov 2026, 23:09 IST · after market close · Suraksha Diagnostic Ltd (SURAKSHA)
Key takeaways
- Consolidated revenue rose +13.03% QoQ, outpacing expenses at +12.34% and lifting operating margin by 0.41 percentage points.
- Net profit increased +16.34% QoQ even as interest expense rose +30.11%, helped partly by a 1.49 percentage-point reduction in the tax rate.
- Suraksha's 35.14% operating margin stood 13.49 percentage points above the 21.65% median of 90 reported Healthcare peers.
Price around the results
Q2FY27 growth accelerated on a favourable cost mix
Suraksha Diagnostic's consolidated revenue grew +13.03% QoQ, while expenses increased +12.34%, allowing operating profit to rise +14.36%. That modest operating leverage lifted the margin by 0.41 percentage points to 35.14%, rather than relying on a sharp reduction in costs.
Lower tax helped offset higher financing and depreciation costs
Interest expense increased +30.11% QoQ and depreciation rose +11.79%, limiting the conversion of operating profit into pre-tax profit. Net profit still grew +16.34%, helped by a tax-rate reduction of 1.49 percentage points to 20.78%. Other income accounted for 7.95% of pre-tax profit, so it was a supplementary rather than the main earnings driver.
Margin remains well above the reported Healthcare peer median
Suraksha's 35.14% operating margin was 13.49 percentage points above the 21.65% median among 90 Healthcare peers that had reported the quarter. With only Q1FY27 available in the trend, the sequential margin improvement is visible, but a longer multi-quarter direction cannot be established here. The results were filed after market close, leaving no post-results market reaction to assess in this update.
Q2FY27 at a glance
Consolidated figures as filed with NSE — filed ahead of third-party databases, not yet independently cross-checked.
| Line item | Q2FY27 | Q1FY27 | QoQ |
|---|---|---|---|
| Revenue | ₹99 cr | ₹88 cr | +13.03% |
| Other income | ₹2 cr | ₹1 cr | +37.61% |
| Expenses | ₹64 cr | ₹57 cr | +12.34% |
| Operating profit | ₹35 cr | ₹30 cr | +14.36% |
| Operating margin (%) | 35.14% | 34.73% | — |
| Interest | ₹5 cr | ₹4 cr | +30.11% |
| Depreciation | ₹13 cr | ₹11 cr | +11.79% |
| Profit before tax | ₹19 cr | ₹17 cr | +14.16% |
| Tax | ₹4 cr | ₹4 cr | +6.52% |
| Net profit | ₹15 cr | ₹13 cr | +16.34% |
| EPS (₹) | ₹2.88 | ₹2.50 | +15.20% |
Operating margin of 35.14% compares with a Healthcare sector median of 21.65% across 90 peers that have reported Q2FY27.
What to watch
- Whether revenue growth remains ahead of the +12.34% QoQ expense growth rate.
- Whether operating margin holds above 35.14%.
- Whether interest-expense growth eases from +30.11% QoQ.